Focus Groups About Drug Products As Used by The Food and Drug Administration

ICR 201703-0910-009

OMB: 0910-0677

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement B
2017-03-15
Supporting Statement A
2017-03-15
ICR Details
0910-0677 201703-0910-009
Historical Active 201604-0910-008
HHS/FDA CDER
Focus Groups About Drug Products As Used by The Food and Drug Administration
Extension without change of a currently approved collection   No
Regular
Approved without change 05/18/2017
Retrieve Notice of Action (NOA) 03/15/2017
This generic clearance for FDA/CDER focus groups is approved for 3-years under the following conditions: (1) For individual focus groups, FDA shall submit a generic IC in ROCIS along with: (a) an abbreviated supporting statement in the template agreed to by OMB and FDA (including a statement of need, intended use of information, description of respondents, date(s) and location(s), collection procedures, number of focus groups, justification for any proposed incentive, and estimated burden); (b) the participant screener, and (c) moderator guide. (2) OMB will respond with clearance or questions within 10 working days.
  Inventory as of this Action Requested Previously Approved
05/31/2020 36 Months From Approved 05/31/2017
1,440 0 1,440
2,520 0 2,520
0 0 0

The information collection supports agency research through focus groups. This is a generic collection regarding drug products regulated by FDA and information collection is limited to this topic.

US Code: 21 USC 393(d)(2)(D) Name of Law: FFDCA; Commissioner may conduct research
  
None

Not associated with rulemaking

  81 FR 78161 11/07/2016
82 FR 13816 03/15/2017
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,440 1,440 0 0 0 0
Annual Time Burden (Hours) 2,520 2,520 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$200,000
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Domini Bean 301 796-5733 domini.bean@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/15/2017


© 2024 OMB.report | Privacy Policy